CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality EXCELling in Left Main Intervention Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes Coronary Atherosclerotic Precursors of Acute Coronary Syndromes Plaque composition by intravascular ultrasound and distal embolization after percutaneous coronary intervention Bioprosthetic valve oversizing is associated with increased risk of valve thrombosis following TAVR Transcatheter Aortic Valve Implantation Represents an Anti-Inflammatory Therapy Via Reduction of Shear Stress-Induced, Piezo-1-Mediated Monocyte Activation

Clinical Trial4 Apr 2022

JOURNAL:Circulation. Article Link

Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial

D-W Park, J-M Ahn, D-Y Kang et al. Keywords: TAVR; without an indication for long-term anticoagulation; subclinical leaflet thrombosis

Full Text PDF